Biotechnologies

<!-- Name:DistributionId Value:8837593 --> <!--…
Read More...

<!-- Name:DistributionId Value:8830389 --> <!--…
Read More...

<!-- Name:DistributionId Value:8805377 --> <!--…
Read More...

<!-- Name:DistributionId Value:8793597 --> <!--…
Read More...

SEATTLE, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq:…
Read More...

SAN DIEGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the…
Read More...

SEATTLE, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq:…
Read More...

- Data demonstrating that Ixo-vec was generally well tolerated and that a single intravitreal (IVT) injection can lead…
Read More...

HILLERØD, Denmark, Oct. 27, 2022 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies, a world leading contract…
Read More...

SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or…
Read More...